These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16704960)

  • 1. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection.
    Gordeuk VR; Onojobi G; Schneider MF; Dawkins FW; Delapenha R; Voloshin Y; von Wyl V; Bacon M; Minkoff H; Levine A; Cohen M; Greenblatt RM
    Haematologica; 2006 Jun; 91(6):739-43. PubMed ID: 16704960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iron metabolism in patient infected by human immunodeficiency virus type 1].
    Arévalo Velasco A; Mateo Rodríguez F; Sánchez Pérez MA; Alonso Claudio G; Pérez Arellano JL; Fuertes Martín A
    Sangre (Barc); 1997 Oct; 42(5):345-9. PubMed ID: 9424732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
    J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron status and indicators of human immunodeficiency virus disease severity among pregnant women in Malawi.
    Semba RD; Taha TE; Kumwenda N; Mtimavalye L; Broadhead R; Miotti PG; Chiphangwi JD
    Clin Infect Dis; 2001 May; 32(10):1496-9. PubMed ID: 11317253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection.
    Delanghe JR; Langlois MR; Boelaert JR; Van Acker J; Van Wanzeele F; van der Groen G; Hemmer R; Verhofstede C; De Buyzere M; De Bacquer D; Arendt V; Plum J
    AIDS; 1998 Jun; 12(9):1027-32. PubMed ID: 9662199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.
    Lavreys L; Baeten JM; Chohan V; McClelland RS; Hassan WM; Richardson BA; Mandaliya K; Ndinya-Achola JO; Overbaugh J
    Clin Infect Dis; 2006 May; 42(9):1333-9. PubMed ID: 16586394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D; Creagh T; Leitz G;
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T
    Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus.
    López-Gatell H; Cole SR; Hessol NA; French AL; Greenblatt RM; Landesman S; Preston-Martin S; Anastos K
    Am J Epidemiol; 2007 May; 165(10):1134-42. PubMed ID: 17339383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between markers of HIV-1 disease progression and serum beta-carotene concentrations in Kenyan women.
    Baeten JM; McClelland RS; Wener MH; Bankson DD; Lavreys L; Mandaliya K; Bwayo JJ; Kreiss JK
    Int J STD AIDS; 2007 Mar; 18(3):202-6. PubMed ID: 17362556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin levels in normal and HIV-1 infected pregnant women.
    Phuapradit W; Taeepanichskul S; Jetsawangsri T; Chaturachinda K; Khupulsup K; Kunakorn M
    Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):24-6. PubMed ID: 8775245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.